@article{JTD24331,
author = {Alessia Spagnuolo and Cesare Gridelli},
title = {“Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer”: is there a substantial difference or not?},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 33},
year = {2018},
keywords = {},
abstract = {Metastatic non-small cell lung cancer (NSCLC) is still an incurable disease, despite the significant improvement in prognostic outcomes [progression-free survival (PFS) and overall survival (OS)] which has been seen in recent years following the advent of immunomodulatory drugs aimed at inhibiting immune checkpoints.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/24331}
}